Skip to main content

Table 1 Time points of each assessment index

From: Effects of Shinbaro pharmacopuncture in sciatic pain patients with lumbar disc herniation: study protocol for a randomized controlled trial

Week

Screening (baseline)

1

 

2

 

3

 

4

 

5

7

9

12

Visit

1

2

3

4

5

6

7

8

9

10

11

12

13

Informed consent

o

            

Demographic characteristics, Medical history

o

            

Inclusion/Exclusion criteria

o

            

Blood test

o

        

o

  

o

MRI

o

           

o

Credibility and Expectancy Questionnaire

o

            

Blinding test

   

o

         

Randomization

 

o

           

Treatment

 

o

o

o

o

o

o

o

o

    

Education program

 

o

 

o

 

o

 

o

 

o

o

o

o

NRS

o

o

o

o

o

o

o

o

o

o

o

o

o

VAS

 

o

 

o

 

o

 

o

 

o

o

o

o

ODI

 

o

 

o

 

o

 

o

 

o

o

o

o

Physical examination

 

o

 

o

 

o

 

o

 

o

o

o

o

SF-36

 

o

       

o

o

 

o

EQ-5D

 

o

       

o

o

 

o

PGIC

         

o

o

 

o

Safety assessment

 

o

o

o

o

o

o

o

o

o

o

o

o

Use of medication

 

o

o

o

o

o

o

o

o

o

o

o

o

  1. EQ-5D EuroQol-5 Dimension, MRI magnetic resonance imaging, ODI Oswestry Disability Index, NRS, Numeric Rating Scale, PGIC patient global impression of change, SF-36 Short Form Health Survey 36, VAS Visual Analog Scale